Janumet Tab 50mg,1000mg 14's
Janumet Tab 50mg,1000mg 14’s

JANUMET 50/1000MG TAB

Amaryl Tab 2mg 2x15's Amaryl Tab 2mg 2×15’s
Janumet 50mg,500mg tablet Janumet 50mg, 500mg tablet
Janumet Tab 50mg,1000mg 14's

JANUMET 50/1000MG TAB

₨1,000.00

In stock
0 out of 5
( There are no reviews yet. )

₨1,000.00

Pack Size:2×7’s tablet

Composition:Sitagliptin (50mg)
Metformin (1000mg)

Pharmaceutical form: Tablets

Brand Name: [button link=”https://www.almishkat.pk/product-category/brand-companies/MERCK-MARKER-PVT-LTD/” color=”purple” newwindow=”yes”] MERCK MARKER PVT LTD[/button]

Availability: In stock

Add to wishlist

Description

Janumet Tab 50mg,1000mg 14’s

Janumet Tab 50mg,1000mg 14’s is combines two antihyperglycaemic medicinal products with complementary mechanisms of action to improve glycaemic control in patients with type 2 diabetes: sitagliptin phosphate, a dipeptidyl peptidase 4 (DPP-4) inhibitor, and metformin hydrochloride, a member of the biguanide class. Sitagliptin.
Janumet should generally be given twice daily with meals. The dose will be increased slowly to reduce gastrointestinal side effects associated with metformin. The starting dose of Janumet should be based on the patient’s current regimen.

For patients using Janumet immediate-release tablets: Adults—The dose is the same as the dose you are already taking. Your doctor may gradually increase your dose until your blood sugar is controlled. However, the dose is usually not more than 100 mg of sitagliptin and 2000 mg of metformin once a day.

Uses

Monotherapy: This medicine is used for treating type 2 diabetes (condition characterized by elevated glucose levels) that is inadequately controlled by metformin, diet and exercise.

Dual therapy: It is used for treating diabetes type 2 along with metformin or a glitazone when patients respond inadequately to diet changes, exercise and either metformin or glitazine, or in combination with sulphonylureas in patients contraindicated for metformin, and for patients that do not respond adequately to sulphonylureas alone.

Triple therapy: This medicine is used with metformin and a sulphonylureas or glitazone for treating diabetes 2 that is inadequately controlled by dual therapy.

With insulin: This medicine is used with or without metformin for treating type 2 diabetes in patients who respond inadequately to diet, exercise, and insulin.

Side Effects

The patients administered with this medicine may experience pancreatitis (inflammation of pancreas), allergic reactions, Stevens-Jhonson Syndrome (allergic reaction), Hypoglycemia (low glucose levels), bullous pemphigoid (large fluid-filled blisters), osteoarthritis (weak bones), upper respiratory tract infections, flatulence, swelling, and influenza (flu-like symptoms).

When Not To Use

The patients with diabetic ketoacidosis (condition causing fat breakdown at an abnormal rate) and moderate to severe renal (kidney) impairment should avoid use of this medicine.

Reviews

There are no reviews yet.

Be the first to review “JANUMET 50/1000MG TAB”